Liver Diseases  >>  Inlyta (axitinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Withdrawn
1b
0
US
Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib
Pfizer
Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular
11/13
11/13
NCT00692341: Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics

Completed
1
24
US
AG-013736
Pfizer
Hepatic Insufficiency
10/08
10/08

Download Options